Luye Pharma Group announced that the marketing authorization application for the company's oncology product, LY01008 (Bevacizumab injection), has been accepted by the China Center for Drug Evaluat...
Expert Committee on Breast Cancer of the Chinese Society of Clinical Oncology (CSCO BC), an authoritative Chinese oncology institution, recently published the 2020 CSCO Guidelines on Diagnosis and Tre...
Singapore, April 6, 2020: Luye Medical Group today donated surgical face masks to the Singapore Cancer Society to help cancer patients combat the COVID-19 outbreak. Kenneth Foo, Deputy Director of Sin...
Luye Pharma Group (02186.HK) reported its financial results for 2019 on March 27, 2020. According to the results, the company has achieved a total revenue of RMB 6.358 billion, up 22.9% year-on-year. ...
Luye Pharma Group has announced that the U.S. Food and Drug Administration (FDA) has reviewed and accepted the filing of a New Drug Application (NDA) for LY03005, a new chemical drug for the treatment...
Luye Pharma Group has announced that it has entered into an exclusive distribution and marketing service agreement with Cipla Medpro South Africa (Pty) Limited (Cipla Medpro), for Seroquel® and Seroqu...
PharmaMar, one of Luye Pharma’s collaborative partners, has announced that the U.S. Food and Drug Administration (FDA) has accepted for filing with Priority Review the New Drug Application (NDA)...
December 1, 2019, Luye Pharma Group has announced the acquisition of Shandong Boan Biological Technology Co. Ltd. (Boan), accelerating its global strategy in the field of biopharmaceuticals. After the...
As one of the nation’s largest private mental health providers, October 10 is a very important date for Healthe Care, annually. It marks World Mental Health Day, an international day for global ...
Fairfield, NJ (November 5, 2019)-Vela Diagnostics announced that it has received FDA authorization to market its in vitro diagnostic test for the detection of HIV-1 genomic drug resistance mutations (...
TOP